The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COM | 901384107 | 871 | 59,833 | SH | SOLE | 59,833 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 4,080 | 249,400 | SH | SOLE | 249,400 | 0 | 0 | ||
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 3,424 | 2,252,388 | SH | SOLE | 2,252,388 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 2,265 | 117,000 | SH | SOLE | 117,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 1,117 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 397 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | ||
ANGION BIOMEDICA CORP | COM | 03476J107 | 50 | 54,392 | SH | SOLE | 54,392 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 820 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 667 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
ASPIRA WOMEN'S HEALTH INC | COM | 04537Y109 | 22 | 60,070 | SH | SOLE | 60,070 | 0 | 0 | ||
ALPHATEC HOLDINGS INC | COM | 02081G201 | 87 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | COM | 053588307 | 1,152 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
AZIYO BIOLOGICS INC | COM | 05479K106 | 10,210 | 1,418,123 | SH | SOLE | 1,418,123 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 252 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
BIODESIX INC | COM | 09075X108 | 3,010 | 2,370,071 | SH | SOLE | 2,370,071 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | COM | G11196105 | 2,227 | 14,730 | SH | SOLE | 14,730 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 620 | 98,000 | SH | SOLE | 98,000 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 51,738 | 727,785 | SH | SOLE | 727,785 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 1,033 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 134 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
CONTINENTAL RESOURCES INC | COM | 212015101 | 2,579 | 38,600 | SH | SOLE | 38,600 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 34 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 1,282 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CULLINAN MANAGEMENT INC | COM | 230031106 | 322 | 25,114 | SH | SOLE | 25,114 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 1,211 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
DOCGO INC | COM | 256086109 | 1,091 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
EQUITRANS MIDSTREAM CORPORATIO | COM | 294600101 | 995 | 133,050 | SH | SOLE | 133,050 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 2,272 | 264,843 | SH | SOLE | 264,843 | 0 | 0 | ||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 500 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 1,906 | 159,088 | SH | SOLE | 159,088 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 2,173 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 717 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
INARI MEDICAL INC | COM | 45332Y109 | 726 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 185 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
INHIBRX INC | COM | 45720L107 | 1,265 | 70,448 | SH | SOLE | 70,448 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 501 | 4,000 | SH | SOLE | 4,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 449 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 580 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,471 | 269,332 | SH | SOLE | 269,332 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM | G5269C101 | 385 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
LAIRD SUPERFOOD INC | COM | 50736T102 | 51 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 2,157 | 15,280 | SH | SOLE | 15,280 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 410 | 128,000 | SH | SOLE | 128,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 9,053 | 85,240 | SH | SOLE | 85,240 | 0 | 0 | ||
OVINTIV INC | COM | 69047Q102 | 3,873 | 84,200 | SH | SOLE | 84,200 | 0 | 0 | ||
PHREESIA INC | COM | 71944F106 | 2,107 | 82,700 | SH | SOLE | 82,700 | 0 | 0 | ||
PIONEER NATURAL RESOURCES CO | COM | 723787107 | 823 | 3,800 | SH | SOLE | 3,800 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 320 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 7,212 | 118,945 | SH | SOLE | 118,945 | 0 | 0 | ||
QUIDELORTHO CORP | COM | 74838J101 | 4,382 | 61,306 | SH | SOLE | 61,306 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 276 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | ||
SIENTRA INC | COM | 82621J105 | 26 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
SILK ROAD MEDICAL INC | COM | 82710M100 | 450 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203101 | 409 | 245,127 | SH | SOLE | 245,127 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 193 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 3,141 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 1,571 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 320 | 12,300 | SH | SOLE | 12,300 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 361 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
YIELD10 BIOSCIENCE INC | COM | 98585K102 | 56 | 18,750 | SH | SOLE | 18,750 | 0 | 0 |